aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
aVenture is in Alpha: aVenture recently launched early public access to our research product. It's intended to illustrate capabilities and gather feedback from users. While in Alpha, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to temporarily present this information to showcase the product's potential, but you should not yet rely upon it for your investment decisions.
© aVenture Investment Company, 2024. All rights reserved.
44 Tehama St, San Francisco, CA 94105
Privacy Policy
aVenture Investment Company ("aVenture") is an independent venture capital research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals.
While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision.
aVenture does not offer investment advisory services and is not registered as an investment adviser. The data provided by aVenture does not constitute recommendations or advice, whether by methodology or a statement written by a staff member of aVenture.
Links to external websites do not imply endorsement or affiliation with aVenture. References or links to providers offering the ability to invest in a primary or secondary transaction in a company are for convenience purposes only. They are not solicitations or offers to buy or sell an investment. Remember that past performance does not guarantee future results, and venture capital and private assets should be a contributory part of a diversified portfolio.
Complexa, Inc. is a biopharmaceutical company dedicated to discovering and developing innovative therapies for the treatment of inflammatory and metabolic diseases. Their mission is to improve patient outcomes through advanced scientific research and cutting-edge medical solutions, focusing on unmet medical needs in these critical areas.
Complexa has made significant strides in the biopharmaceutical industry, contributing to advancements in therapeutic options for complex diseases. Their impactful research and development efforts have positioned them as a key player in the field, driving progress and offering hope to patients worldwide.
Operating Status
Active
Ownership Type(s)
Public
Main Product(s)
Therapeutics
Technology
Biotech
Model Types
Software
Revenue Type(s)
Recurring
Customer Type(s)
Enterprise
Geographic Exposure
Global
When was Complexa founded?
Complexa was founded in 2008.
Where is Complexa’s headquarters located?
Complexa’s headquarters is located in Pittsburgh, PA, US.
When was Complexa’s last funding round?
Complexa’s most recent funding round was for $62M (USD) in July 2017.
How many employees does Complexa have?
Complexa has 7 employees as of Feb 5, 2024.
How much has Complexa raised to-date?
As of July 05, 2023, Complexa has raised a total of $86.9M (USD) since Jul 26, 2017.
Add Comparison
Total Raised to Date
$86.9M
USD
Last Update Jul 26, 2017
Last Deal Details
$62M
USD
Jul 26, 2017
Series C
Total Employees Over Time
7
As of Feb 2024
Complexa Address
2425 Sidney St
Pittsburgh,
Pennsylvania
15203
United States
Source(s): This page includes data and analysis provided by the company, OpenAI, and our research analysts